Match Document Document Title
7601362 Gelled bait  
An effective gelled poison bait is provided for the control of such objective insect as cockroaches, wherein the bait comprises 1-methyl-2-nitro-3-[(tetrahydrofuryl)methyl]guanidine, carrageenan,...
7589111 C10 cyclopentyl ester substituted taxanes  
A taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3′ and an isopropoxycarbamate substituent at C3′.
7589089 Inhibitors for GlyT-1  
The present invention relates to compounds of formula I wherein R 1 , R 2 , R 3 , R 4 , and X are as defined herein or to pharmaceutically acceptable acid addition salts thereof, with the...
7547716 Sulfonamide derivatives  
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the general formula (I) or a...
7534768 Treatment of DNA viral infections  
The synergistic combination of a loop diuretic and a cardiac glycoside is useful in the treatment of DNA viral infections.
7528157 EP4 receptor antagonists  
Compounds of formula (I): wherein: R 2 is H or an optionally substituted C 1-4 alkyl group; Y is either —(CH 2 ) n —X—, where n is 1 or 2 and X is O, S, S(═O), S(═O) 2 , or NR N1 ,...
7524869 Taxanes having a C10 ester substituent  
Taxanes having an ester substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substituents.
7514452 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same  
The present invention provides 2-furancarboxylic acid hydrazide compounds represented by General Formula (I) below, and prodrugs, physiologically acceptable salts, hydrates, solvates thereof: ...
7495023 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use  
The present invention relates to thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of using such compounds to prevent and treat protozoan infections such as...
7491740 Isoxazoline compounds having MIF antagonist activity  
Methods of use and pharmaceutical compositions for a genus of low molecular weight compounds comprising optionally substituted isoxazoline ring systems that act as inhibitors of MIF (macrophage...
7468449 Phenyl-furan compounds as vitamin D receptor modulators  
The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25dihydroxy vitamin D3....
7468360 Therapeutic amides and related compounds  
Disclosed herein is a compound having a structure: Therapeutic methods, compositions, and medicaments relating thereto are also disclosed.
7465718 Ansamycins having improved pharmacological and biological properties  
Ansamycins and methods of preparing and using the same are described. At least some of these ansamycins exhibit one or more of improved aqueous formulation ability, chemical stability, and...
7429390 Stable pharmaceutical compositions, processes for making the same and methods of their use  
The present invention is generally related to alcohol free, liquid ranitidine formulations for oral administration. In particular, the present invention is related to stable, syrup formulations...
7423170 Anticancer agents based on regulation of protein prenylation  
Oncoproteins such as Ras and RhoB are known to induce cell division in an unrestrained manner when such proteins are localized at the inner surface of a cancer cell membrane. The localization is...
7417057 Pesticidal heterocycles  
It has now been found that certain novel heterocyclic derivatives have provided unexpected insecticidal activity. These compounds are represented by formula (I): R Preferred are those compounds of...
7396858 Biguanide derivative and therapeutic agent for diabetes containing the same  
Diabetes treatments comprising, as effective ingredients, biguanide derivatives represented by the following general formula (1), or salts thereof. (wherein R 1 , R 2 and R 3 may be the same...
7387798 Method and composition for resuscitation  
The key obstacle for current resuscitation is the acutely limited time window. The major reason for the limited time window is that the brain and spinal cord are extremely vulnerable to...
7378448 Diphenylether amide derivatives as opioid receptor antagonists  
A compound of the formula (I) wherein the variables X 1 , X 2 , B, D, R 1 to R 7 including R 3′ , p, y, q, and z, are as defined or a pharmaceutically acceptable salt, solvate, enantiomer,...
7368435 Topical endoparasiticide and ectoparasiticide formulations  
A topical formulation having significant parasiticidal activity effective against endoparasites and/or ectoparasites such as heartworms, mites, fleas, ticks, flies is provided, which can be safe to...
7365085 Compounds and methods  
Disclosed is a compound having the formula: pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are...
7345092 High concentration topical insecticides containing pyrethroids  
A topical insecticide preparation is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. The topical insecticide contains a...
RE40000 Method of treatment for decreasing mortality resulting from congestive heart failure  
A method of treatment using a compound of Formula I: wherein: R 1 is hydrogen, lower alkanoyl of up to 6 carbon atoms or aroyl selected from benzoyl and naphthoyl; R 2 is hydrogen,...
7314885 Pyrrole compounds useful as kinase inhibitors  
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds, processes for...
7312239 Medicament for prevention and/or therapy of arterial wall disorder  
An object of the present invention is to provide a medicament and method which is useful for prevention and/or therapy of arterial wall injury. According to the present invention, there is provided...
7291621 Substituted biaryl amides C5a receptor modulators  
Substituted biaryl amides of Formula I are provided. Such compounds are ligands that may be used to modulate C 5 a receptor activity in vivo or in vitro, and are particularly useful in the...
7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators  
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being...
7241795 Synthesis and antimicrobial activity of novel dicationic “reversed amidines”  
The present invention relates to novel 2,5-bis{[alkyl (or aryl) imino]aminophenyl}furans and thiophenes of the general formula in which R 1 , R 2 , R 3 and R 4 are each independently selected...
7226944 Taxanes having a C7 carbonate substituent  
Taxanes having a carbonate substituent at C(7), a hydroxy substituent at C(10), and a range of C(2), C(9), C(14), and side chain substituents.
7217706 Propanolamine derivatives  
This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: Wherein each symbol is as defined in the specification or salts thereof which...
7214708 Synthetic discodermolide analogs  
Synthetic discodermolide analogs having utility as antiproliferative agents, having a structure represented by formula A where R A through R E and X A are as defined herein.
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7208528 Polyamine analogues as therapeutic and diagnostic agents  
Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical...
7196089 EP4 receptor antagonists  
Compounds of formula (I): wherein: R 2 is H or an optionally substituted C 1-4 alkyl group; Y is either —(CH 2 ) n —X—, where n is 1 or 2 and X is O, S, S(═O), S(═O) 2 , or NR N1 ,...
7192951 Treatment of congestive heart failure  
Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to...
7183316 Treatment of HPV caused diseases  
Human papillomavirus (HPV) protein expression is downregulated in patients infected with HPV by administration of PPARγ ligand, selective inhibitor of cyclooxygenase-2 (COX-2), diaryl heterocycle,...
7179840 Furancarboxamides  
This invention relates to novel furancarboxamides of the formula (I) in which R, R 1 and m are as defined in the disclosure, to a plurality of processes for preparing these substances and to...
7176201 Modulation of anxiety through blockade of anandamide hydrolysis  
Fatty acid amide hydrolase inhibitors of the Formula: are provided wherein X is NH, CH 2 , O, or S; Q is O or S; Z is O or N; R is an aromatic moiety selected from the group consisting of...
7160916 Method of increasing bone density or treating osteoporosis  
This invention features a method for enhancing bone growth or inhibiting bone resportion. The method includes administering to a subject in need thereof a compound of the following formula: A...
7157078 Devices and methods for eliminating termite colonies  
This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected...
7153869 Substituted amino acids as erythropoietin mimetics  
This invention relates to a series of substitituted amino acids of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the...
7135499 Active substance combinations having insecticidal and acaricidal properties  
The present invention relates to novel insecticidally and acaricidally active compound combinations of N 2 -[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N 1...
7132448 High concentration topical insecticide containing insect growth regulator  
A topical insecticide is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. The insecticide contains an insecticide and an...
7132445 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands  
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic...
7132441 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor  
This invention is in the field of a combination comprising a therapeutically-effective amount of a cyclooxygenase-2 inhibitor, a 5-lipoxygenase inhibitor and an immunosuppressive drug selected from...
7129238 Mandelic acid derivatives  
The invention is concerned with novel mandelic acid derivatives of formula (I) wherein R 1 to R 10 , X and Y are as defined in the description and in the claims, as well as pharmaceutically...
7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2  
Compounds useful as inhibitors of cyclooxygenase-2 activity have the formulae I or Ia: wherein: Q 1 , Q 2 , n, m, X, Y and R are as defined herein.
7109243 Inhibitors of cathepsin S  
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at...
7105564 Pharmaceutical composition comprising a dual antagonist against PGD2/TXA2 receptors having a [2.2.1] or [3.1.1] bicyclic skeleton  
The present invention provides novel compounds having a dual antagonistic activity against thromboxane A2 receptor and prostaglandin D 2 receptor and pharmaceutical compositions comprising them. ...
7105545 N-p-propargyloxyphenethyl-thioacetic acid amides  
The invention relates to N-propargyloxy-phenethyl thioacetic acid amide derivatives of the general formula (I) including the optical isomers thereof and mixtures of such isomers, wherein R 1 is...